INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease

INPP5D 缺乏可减轻阿尔茨海默病小鼠模型中的淀粉样蛋白病理

阅读:9
作者:Peter Bor-Chian Lin, Andy Po-Yi Tsai, Disha Soni, Audrey Lee-Gosselin, Miguel Moutinho, Shweta S Puntambekar, Gary E Landreth, Bruce T Lamb, Adrian L Oblak

Conclusion

These data demonstrate that Inpp5d haplodeficiency enhances microglial functions by increasing plaque clearance and preserves cognitive abilities in 5xFAD mice. Inhibition of INPP5D is a potential therapeutic strategy for AD.

Methods

We used the 5xFAD mouse model of amyloidosis to assess how Inpp5d haplodeficiency regulates amyloid pathogenesis.

Results

Inpp5d haplodeficiency perturbs the microglial intracellular signaling pathways regulating the immune response, including phagocytosis and clearing of amyloid beta (Aβ). It is important to note that Inpp5d haploinsufficiency leads to the preservation of cognitive function. Spatial transcriptomic analysis revealed that pathways altered by Inpp5d haploinsufficiency are related to synaptic regulation and immune cell activation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。